{"id":"doacs-rivaroxaban-dabigatran-apixaban","safety":{"commonSideEffects":[{"rate":"null","effect":"Gastrointestinal bleeding"},{"rate":"null","effect":"Hemorrhage"},{"rate":"null","effect":"Anemia"}]},"_chembl":{"chemblId":"CHEMBL198362","moleculeType":"Small molecule","molecularWeight":"435.89"},"_fixedAt":"2026-03-30T13:38:57.600202","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"They work by directly inhibiting the coagulation cascade at the level of Factor Xa or thrombin, preventing the formation of blood clots. This is in contrast to traditional anticoagulants like warfarin, which work by inhibiting the production of vitamin K-dependent clotting factors.","oneSentence":"Rivaroxaban, dabigatran, and apixaban are direct oral anticoagulants that inhibit Factor Xa or thrombin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:10:59.511Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Deep vein thrombosis and pulmonary embolism treatment and prevention"}]},"_fixedFields":["pubmed(6)"],"trialDetails":[{"nctId":"NCT03568890","phase":"PHASE4","title":"Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec","startDate":"2018-09-01","conditions":"Left Atrial Appendage Closure, Thrombosis, Stroke","enrollment":510},{"nctId":"NCT05825573","phase":"PHASE3","title":"Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-05-15","conditions":"Intracardiac Thrombus, STEMI, Heart Failure","enrollment":340},{"nctId":"NCT04045665","phase":"PHASE3","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2019-12-13","conditions":"Atrial Fibrillation, Stroke, Bleeding","enrollment":3200},{"nctId":"NCT04284839","phase":"PHASE3","title":"The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial","status":"RECRUITING","sponsor":"Population Health Research Institute","startDate":"2021-07-18","conditions":"Bleeding Post Cardiac Surgery, Indication for Anticoagulation","enrollment":3500},{"nctId":"NCT03778502","phase":"","title":"DOAC in Unusual Site Venous Thrombosis","status":"COMPLETED","sponsor":"University of Malta","startDate":"2019-10-01","conditions":"Splanchnic Vein Thrombosis, Cerebral Vein Thrombosis, Ovarian Vein Thrombosis","enrollment":358},{"nctId":"NCT07011095","phase":"EARLY_PHASE1","title":"DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial","status":"NOT_YET_RECRUITING","sponsor":"Population Health Research Institute","startDate":"2025-09-03","conditions":"Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation)","enrollment":100},{"nctId":"NCT06983795","phase":"","title":"Pioneering Advancements in Cardiocerebrovascular Interactions in the Asia pacFIC - Patent Foramen Ovale Study","status":"NOT_YET_RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2025-07","conditions":"Ischemic Stroke, Patent Foramen Ovale","enrollment":1000},{"nctId":"NCT03129490","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":11000},{"nctId":"NCT04700826","phase":"PHASE4","title":"Preventing Stroke, Premature Death and Cognitive Decline in a Broader Community of Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2021-06-01","conditions":"Atrial Fibrillation","enrollment":3000},{"nctId":"NCT03129555","phase":"PHASE4","title":"The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Herlev and Gentofte Hospital","startDate":"2023-04-01","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":5000},{"nctId":"NCT06957366","phase":"NA","title":"Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure","status":"RECRUITING","sponsor":"McMaster University","startDate":"2025-04-01","conditions":"Atrial Fibrillation (AF), VTE","enrollment":920},{"nctId":"NCT05735639","phase":"PHASE4","title":"THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2024-01-22","conditions":"Venous Thromboembolism, Varicose Veins","enrollment":6660},{"nctId":"NCT04394234","phase":"","title":"A Study of Severe Uterine Bleeding Following Exposure to Direct Oral Anticoagulants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-05-15","conditions":"Uterine Hemorrhage","enrollment":961985},{"nctId":"NCT06449469","phase":"NA","title":"The Nordic Aortic Valve Intervention Trial 4 (NOTION-4)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-05-01","conditions":"Aortic Valve Stenosis, Cardiovascular Diseases, Heart Diseases","enrollment":352},{"nctId":"NCT06322953","phase":"PHASE3","title":"Timing to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage","status":"RECRUITING","sponsor":"Walton Centre NHS Foundation Trust","startDate":"2025-03-10","conditions":"Traumatic Intracranial Haemorrhage","enrollment":1084},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT05750680","phase":"","title":"DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-05-13","conditions":"Atrial Fibrillation, Thromboembolism, Venous","enrollment":23},{"nctId":"NCT05068414","phase":"","title":"Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2021-04-12","conditions":"Atrial Fibrillation, Acute Coronary Syndrome, Thrombosis","enrollment":122},{"nctId":"NCT05378035","phase":"","title":"DOAC in Chinese Patients With Atrial Fibrillation","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2022-09-28","conditions":"Atrial Fibrillation, Stroke, Stroke, Acute","enrollment":427},{"nctId":"NCT03996772","phase":"PHASE3","title":"PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2019-06-03","conditions":"Atrial Fibrillation, Intracerebral Hemorrhage","enrollment":319},{"nctId":"NCT04979780","phase":"","title":"Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort","status":"COMPLETED","sponsor":"Bayer","startDate":"2021-07-20","conditions":"Treatment of Venous Thromboembolism in Cancer Patients, Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients","enrollment":3708},{"nctId":"NCT03596502","phase":"","title":"Direct Oral Anticoagulants in Patients with Atrial Fibrillation (DOACs Vs Warfarin)","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2018-02-01","conditions":"Atrial Fibrillation, Ischemic Stroke, Systemic Embolization","enrollment":402764},{"nctId":"NCT04477837","phase":"","title":"Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants","status":"COMPLETED","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2020-10-15","conditions":"Heavy Menstrual Bleeding","enrollment":84},{"nctId":"NCT06556446","phase":"","title":"Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2024-01-01","conditions":"Ischemic Stroke","enrollment":2800},{"nctId":"NCT03759938","phase":"NA","title":"OPTIMAS: OPtimal TIMing of Anticoagulation After Acute Ischaemic Stroke : a Randomised Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University College, London","startDate":"2019-06-18","conditions":"Stroke, Acute, Atrial Fibrillation","enrollment":3648},{"nctId":"NCT05802576","phase":"","title":"Study of Interference Between Oral Anticoagulants and Heparin During Ablation of Atrial Fibrillation (AF) or Left Atrial Tachycardia (GAD) by Catheter.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-07-08","conditions":"Atrial Fibrillation, Atrial Tachycardia","enrollment":100},{"nctId":"NCT04042155","phase":"","title":"Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2019-07-29","conditions":"Atrial Fibrillation, Recurrent Venous Thromboembolism","enrollment":1600},{"nctId":"NCT04262492","phase":"","title":"International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants","status":"RECRUITING","sponsor":"Stéphane Zuily","startDate":"2020-10-21","conditions":"Antiphospholipid Syndrome, Thrombosis, Anticoagulants Causing Adverse Effects in Therapeutic Use","enrollment":500},{"nctId":"NCT06171984","phase":"","title":"Thrombophilia Assessment Under DOAC: Effectiveness of Activated Charcoal","status":"UNKNOWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2022-07-19","conditions":"Thrombophilia","enrollment":200},{"nctId":"NCT06144866","phase":"","title":"Evaluataion of NOAC Levels in Acute Stroke","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2020-05-01","conditions":"Ischemic Stroke, Anticoagulant Adverse Reaction","enrollment":1000},{"nctId":"NCT02744092","phase":"NA","title":"Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer","status":"COMPLETED","sponsor":"Alliance Foundation Trials, LLC.","startDate":"2016-12-13","conditions":"Cancer, Venous Thromboembolism, Deep Vein Thrombosis (DVT)","enrollment":811},{"nctId":"NCT03148457","phase":"NA","title":"Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2017-11-06","conditions":"Ischaemic Stroke","enrollment":2013},{"nctId":"NCT04679298","phase":"","title":"Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Extended","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2021-01-05","conditions":"Anticoagulation With Direct Oral Anticoagulants","enrollment":80},{"nctId":"NCT03977363","phase":"","title":"The Portuguese Survey on Anticoagulated Patients Register (START-Portugal-Register)","status":"TERMINATED","sponsor":"CHAD","startDate":"2020-01-27","conditions":"Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases or Prosthesis","enrollment":25},{"nctId":"NCT04195113","phase":"","title":"Perioperative Anticoagulant Use for Surgery Evaluation Emergency Registry","status":"COMPLETED","sponsor":"McMaster University","startDate":"2019-08-07","conditions":"Atrial Fibrillation, Venous Thromboembolism, Arterial Vascular Disease","enrollment":242},{"nctId":"NCT04002011","phase":"PHASE2","title":"DOAC Versus VKA After Cardiac Surgery","status":"WITHDRAWN","sponsor":"Laval University","startDate":"2022-03-09","conditions":"Anticoagulant-induced Bleeding","enrollment":""},{"nctId":"NCT02219984","phase":"","title":"START-Register: Survey on Anticoagulated Patients Register","status":"RECRUITING","sponsor":"GUALTIERO PALARETI","startDate":"2011-10","conditions":"Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases or Prosthesis","enrollment":15410},{"nctId":"NCT02353585","phase":"","title":"Novel Oral Anticoagulants in Stroke Patients","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-12","conditions":"Ischemic Stroke, Intracranial Hemorrhages","enrollment":1050},{"nctId":"NCT04151680","phase":"","title":"Anticoagulation on Demand After Percutaneous Coronary Intervention in High Bleeding Risk Patients","status":"UNKNOWN","sponsor":"University of Roma La Sapienza","startDate":"2019-12-01","conditions":"Ischemic Heart Disease, Atrial Fibrillation","enrollment":100},{"nctId":"NCT05491460","phase":"PHASE1","title":"Pharmacokinetics and Point of Care Testing of Direct Oral Anticoagulants Subjects","status":"UNKNOWN","sponsor":"Doasense GmbH","startDate":"2022-07-01","conditions":"Anticoagulant Therapy","enrollment":24},{"nctId":"NCT01999179","phase":"NA","title":"Post-thrombotic Syndrome & Predictors of Recurrence in Catheter-related Thrombosis","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2014-06","conditions":"Venous Thrombosis, Neoplasms","enrollment":27},{"nctId":"NCT03182829","phase":"","title":"In Vitro Diagnostic Test for DOAC in Urine","status":"COMPLETED","sponsor":"Doasense GmbH","startDate":"2018-08-22","conditions":"Anticoagulant Therapy","enrollment":880},{"nctId":"NCT02286414","phase":"","title":"Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02","conditions":"Atrial Fibrillation","enrollment":159},{"nctId":"NCT04891861","phase":"PHASE3","title":"Restart TICrH Alpha Pilot Protocol, Restarting DOACs After Traumatic Intracranial Hemorrhage","status":"UNKNOWN","sponsor":"University of Texas at Austin","startDate":"2021-07-01","conditions":"Anticoagulants; Increased","enrollment":100},{"nctId":"NCT04192916","phase":"","title":"Use of Direct Oral Anticoagulants (DOACs) in Patients With Ph-negative Myeloproliferative Neoplasms","status":"COMPLETED","sponsor":"FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS","startDate":"2019-09-01","conditions":"Myeloproliferative Neoplasm","enrollment":442},{"nctId":"NCT03568916","phase":"","title":"Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2016-11","conditions":"Atrial Fibrillation, Ischemic Stroke, Systemic Embolization","enrollment":227579},{"nctId":"NCT02825394","phase":"","title":"Specific PoC Testing of Coagulation in Patients Treated With DOAC 1","status":"UNKNOWN","sponsor":"University Hospital Tuebingen","startDate":"2016-10-13","conditions":"Anticoagulation With NOAC","enrollment":160},{"nctId":"NCT04518735","phase":"","title":"Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study)","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2020-04-01","conditions":"Covid19","enrollment":1707},{"nctId":"NCT04505475","phase":"","title":"Oral Surgery in Patients Taking Direct Oral Anticoagulants","status":"COMPLETED","sponsor":"University of Novi Sad","startDate":"2015-05-25","conditions":"Anticoagulants and Bleeding Disorders, Surgery, Postoperative Hemorrhage","enrollment":82},{"nctId":"NCT03537521","phase":"","title":"Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots","status":"WITHDRAWN","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2020-04","conditions":"Severe Bleeding, Urgent Surgery","enrollment":""},{"nctId":"NCT01722786","phase":"","title":"Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists","status":"COMPLETED","sponsor":"Cardioangiologisches Centrum Bethanien","startDate":"2014-04","conditions":"Severe Bleeding, Urgent Surgery","enrollment":272},{"nctId":"NCT03119116","phase":"","title":"Use of Direct Oral Anticoagulants in UK","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-05-15","conditions":"Stroke","enrollment":31336},{"nctId":"NCT04291287","phase":"","title":"Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)","status":"UNKNOWN","sponsor":"Scientific Institute San Raffaele","startDate":"2020-01-25","conditions":"Atrial Fibrillation, Myocardial Infarction, Anticoagulant-induced Bleeding","enrollment":1500},{"nctId":"NCT03684395","phase":"","title":"Accessibility to New Drugs Versus SOC in Sweden","status":"COMPLETED","sponsor":"Bayer","startDate":"2016-06-15","conditions":"Anticoagulation","enrollment":68056},{"nctId":"NCT02504177","phase":"NA","title":"Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-06","conditions":"Atrial Fibrillation","enrollment":433},{"nctId":"NCT03189069","phase":"","title":"A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2016-10-06","conditions":"Atrial Fibrillation","enrollment":36000},{"nctId":"NCT02623049","phase":"","title":"Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2015-11","conditions":"Atrial Fibrillation and Flutter","enrollment":150},{"nctId":"NCT03182218","phase":"","title":"Periprocedural Direct Oral Anticoagulant Management","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2015-02","conditions":"Periprocedural Complication","enrollment":1100},{"nctId":"NCT02833987","phase":"","title":"Direct Oral Anticoagulants and Venous Thromboembolism","status":"COMPLETED","sponsor":"Canadian Network for Observational Drug Effect Studies, CNODES","startDate":"2015-03","conditions":"Venous Thromboembolism, Major Bleed","enrollment":59525},{"nctId":"NCT03124004","phase":"","title":"Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients","status":"UNKNOWN","sponsor":"University of Trieste","startDate":"2016-08-15","conditions":"Anticoagulant-induced Bleeding, Periodontal Diseases","enrollment":128},{"nctId":"NCT02371070","phase":"","title":"Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 2","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2013-12","conditions":"Anticoagulation With Direct Oral Anticoagulants","enrollment":60},{"nctId":"NCT02371044","phase":"","title":"Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants 1","status":"COMPLETED","sponsor":"University Hospital Tuebingen","startDate":"2013-05","conditions":"Anticoagulation With Direct Oral Anticoagulants","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"recentPublications":[{"date":"2026 Apr","pmid":"41444034","title":"Proposal for a tooth extraction protocol for patients taking direct oral anticoagulants: a clinical trial.","journal":"Oral surgery, oral medicine, oral pathology and oral radiology"},{"date":"2021 Jul","pmid":"34014506","title":"Risk of Severe Abnormal Uterine Bleeding Associated with Rivaroxaban Compared with Apixaban, Dabigatran and Warfarin.","journal":"Drug safety"},{"date":"2020 May","pmid":"32347184","title":"A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population.","journal":"Journal of managed care & specialty pharmacy"},{"date":"2019 Apr 24","pmid":"30427777","title":"Effect of an activated charcoal product (DOAC Stop™) intended for extracting DOACs on various other APTT-prolonging anticoagulants.","journal":"Clinical chemistry and laboratory medicine"},{"date":"2018 Nov","pmid":"30212268","title":"Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population.","journal":"Journal of managed care & specialty pharmacy"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"DOACs: Rivaroxaban, Dabigatran, Apixaban","genericName":"DOACs: Rivaroxaban, Dabigatran, Apixaban","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Rivaroxaban, dabigatran, and apixaban are direct oral anticoagulants that inhibit Factor Xa or thrombin. Used for Atrial fibrillation for stroke prevention, Deep vein thrombosis and pulmonary embolism treatment and prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}